Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Gastrointestinal Stromal Tumors 8Neoplasms 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Leukemia 2Hematologic Neoplasms 2Triple Negative Breast Neoplasms 1Solid Tumor Cancer 1Rare Tumor 1Rare Malignant Neoplasm 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myeloproliferative Disorders 1Melanoma 1Lymphangioleiomyomatosis 1Leukemia, Myeloid, Chronic-Phase 1Digestive System Neoplasms 1Congenital Bone Marrow Failure Syndromes 1Burkitt Lymphoma 1Breast Neoplasms 1Blast Crisis 1

Interventions

Bevacizumab 4Paclitaxel 2Lutetium-177 2Lutetium 2ribociclib 1repotrectinib 1regorafenib 1pembrolizumab 1palbociclib 1olaparib 1lutetium Lu 177 dotatate 1copper dotatate CU-64 1camrelizumab 1atezolizumab 1apatinib 1Tretinoin 1Radiation 1Propranolol 1Leucovorin 1Irinotecan 1Imatinib Mesylate 1Hyperthermic Intraperitoneal Chemotherapy 1Fulvestrant 1Fluorouracil 1Drug Therapy 1Clinical Trials, Phase II as Topic 1Cisplatin 1Cetuximab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Digestive System Neoplasms × Imatinib Mesylate × Clear all
NCT07406633 2026-05-19

KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting

Kumquat Biosciences Inc.

Phase 2 Recruiting
46 enrolled
GastrointestinalSarcoma

Digestive System Neoplasms, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡